Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib.
about
Relative Initial Weight Is Associated with Improved Survival without Altering Tumor Latency in a Translational Rat Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma and Transarterial Embolization.Cylindromatosis--A Protective Molecule against Liver Diseases.Pre-clinical and clinical investigations of metabolic zonation in liver diseases: The potential of microphysiology systems.Extracellular pH is a biomarker enabling detection of breast cancer and liver cancer using CEST MRI.The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma.Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research.
P2860
Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Model Matters: Differences in ...... Therapy Response to Sorafenib.
@en
Model Matters: Differences in ...... Therapy Response to Sorafenib.
@nl
type
label
Model Matters: Differences in ...... Therapy Response to Sorafenib.
@en
Model Matters: Differences in ...... Therapy Response to Sorafenib.
@nl
prefLabel
Model Matters: Differences in ...... Therapy Response to Sorafenib.
@en
Model Matters: Differences in ...... Therapy Response to Sorafenib.
@nl
P2093
P50
P1476
Model Matters: Differences in ...... Therapy Response to Sorafenib.
@en
P2093
Andreas Steingötter
Anna Melissa Schlitter
Annette Feuchtinger
Axel Walch
Claudia Groß
Ernst Rummeny
Horst Zitzelsberger
Irene Esposito
Irina Heid
Juliane Dworniczak
P304
P356
10.1158/1078-0432.CCR-14-2018
P407
P577
2015-05-20T00:00:00Z